PURE BIOSCIENCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.075 USD | +10.29% |
|
+22.95% | -42.17% |
| May. 06 | PURE Bioscience Appoints Darin Zehr to Board of Directors | CI |
| Mar. 22 | PURE Bioscience, Inc. announced that it has received $3 million in funding | CI |
Quotes 5-day view
Delayed Quote OTC Markets| 2024-06-28 | 2024-07-01 | 2024-07-02 | 2024-07-03 | |
|---|---|---|---|---|
| Last | 0.062 $ | 0.06655 $ | 0.068 $ | 0.075 $ |
| Volume | 15 567 | 10 012 | 10 992 | 20 600 |
| Change | -22.40% | +7.34% | +2.18% | +10.29% |
| Opening | 0.07 | 0.06 | 0.07 | 0.08 |
| High | 0.07 | 0.07 | 0.07 | 0.08 |
| Low | 0.06 | 0.06 | 0.07 | 0.08 |
Performance
| 1 day | +10.29% | ||
| 1 week | +22.95% | ||
| Current month | +20.97% | ||
| 1 month | -12.79% | ||
| 3 months | -6.25% | ||
| 6 months | -45.81% | ||
| Current year | -42.17% | ||
| 1 year | -6.25% | ||
| 3 years | -83.43% | ||
| 5 years | -78.47% | ||
| 10 years | -92.99% |
Volumes
marketsDaily volume
20 600
Estimated daily volume
20 600
Avg. Volume 20 sessions
26 036
Daily volume ratio
0.79
Avg. Volume 20 sessions USD
1 952.70
Record volume 1
3 325 118
Record volume 2
2 702 685
Record volume 3
2 297 300
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
8 389 235
Net sales (USD)
1 877 000
Free-Float
59.55 %
Free-Float capitalization (USD)
4 995 635
Average Daily Capital Traded
0.02%
Highs and lows
1 week
0.06
0.08
1 month
0.060.10
Current year
0.060.15
1 year
0.060.17
3 years
0.060.49
5 years
0.062.05
10 years
0.062.05
Indicators
Moving average 5 days
0.07
Moving average 20 days
0.07
Moving average 50 days
0.07
Moving average 100 days
0.08
Price spread / (MMA5)
-6.27%
Price spread / (MMA20)
-6.00%
Price spread / (MMA50)
-3.47%
Price spread / (MMA100)
+12.67%
STIM
RSI 9 days
49.95
RSI 14 days
49.39
Sector Comparison - Other Household Products
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +10.29% | +22.95% | -42.17% | -6.25% | 8.39M | ||
| +0.09% | +1.00% | +11.60% | +5.32% | 25.8B | ||
| -0.82% | -2.09% | -7.10% | -17.39% | 16.45B | ||
| -1.01% | -2.33% | -16.71% | -31.79% | 6.85B | ||
| -0.36% | -3.31% | +2.27% | -3.31% | 5.77B | ||
| -2.03% | -2.64% | -10.72% | +12.76% | 2.89B | ||
| +0.51% | +0.55% | -2.22% | -5.64% | 2.18B | ||
| -1.41% | +14.22% | -1.52% | +103.47% | 2.1B | ||
| 0.00% | -0.20% | +20.14% | +39.93% | 896M | ||
| +0.83% | +0.62% | +6.67% | -3.47% | 658M | ||
| +1.19% | -3.69% | +37.41% | +34.12% | 455M | ||
| +9.98% | +23.52% | -27.34% | +42.37% | 444M | ||
| +0.05% | -5.88% | -13.77% | -5.35% | 332M | ||
| -0.90% | -2.25% | +78.59% | +440.97% | 309M | ||
| +0.61% | +1.85% | +11.49% | -1.20% | 280M | ||
| -1.85% | -8.04% | +12.75% | +33.98% | 257M | ||
| Average | +0.95% | +1.82% | +3.71% | +39.91% | ||
| Weighted average by Cap. | -0.35% | -0.54% | +1.45% | +1.02% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
7cb00.RJQ-imwglqSUuXW5cgmCa3nEGEkxw6bi43cQkNGH7ak.J8Rt_wNLw-7Wyi-KNVP4JDWLe31LjNeEqBhCyavjgM8y2FHlNFbUwaTQBg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:21:35 am | 0.075 | 20,000 | 41,200 |
| 11:21:35 am | 0.075 | 20,000 | 21,200 |
| 09:30:00 am | 0.075 | 500 | 1,200 |
| 09:30:00 am | 0.075 | 500 | 700 |
| 09:30:00 am | 0.075 | 100 | 200 |
Monthly variations
Annual change
| 2024 | -42.16% | ||
| 2023 | +52.96% | ||
| 2022 | -55.55% | ||
| 2021 | -75.61% | ||
| 2020 | +169.66% | ||
| 2019 | -23.68% | ||
| 2018 | -59.79% | ||
| 2017 | +8.37% | ||
| 2016 | -9.17% | ||
| 2015 | +77.78% | ||
| 2014 | -53.04% | ||
| 2013 | +86.96% | ||
| 2012 | -76.34% | ||
| 2011 | -85.36% | ||
| 2010 | +53.10% | ||
| 2009 | -52.92% | ||
| 2008 | -55.94% | ||
| 2007 | +164.77% | ||
| 2006 | +196.63% | ||
| 2005 | -1.11% | ||
| 2004 | -2.17% | ||
| 2003 | +80.39% | ||
| 2002 | -74.63% | ||
| 2001 | -25.21% | ||
| 2000 | -29.26% | ||
| 1999 | +93.75% | ||
| 1998 | +3.23% | ||
| 1997 | -35.42% | ||
| 1996 | -53.85% |
- Stock Market
- Equities
- PURE Stock
- Quotes PURE Bioscience, Inc.
